Fiona Grimm

548 total citations
15 papers, 328 citations indexed

About

Fiona Grimm is a scholar working on Cancer Research, General Health Professions and Molecular Biology. According to data from OpenAlex, Fiona Grimm has authored 15 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 5 papers in General Health Professions and 4 papers in Molecular Biology. Recurrent topics in Fiona Grimm's work include Cancer, Hypoxia, and Metabolism (5 papers), Geriatric Care and Nursing Homes (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Fiona Grimm is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Geriatric Care and Nursing Homes (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Fiona Grimm collaborates with scholars based in United Kingdom, United States and Sweden. Fiona Grimm's co-authors include Cédric Cortijo, Sebastian N. Stehr, Jernej Ule, Jaya Krishnan, Melis Kayikci, Niklaus Fankhauser, Thierry Pedrazzini, Yann Christinat, Manuel Hörl and Samuel Sossalla and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The EMBO Journal.

In The Last Decade

Fiona Grimm

15 papers receiving 324 citations

Peers

Fiona Grimm
Cristiane Kaufmann United States
Elizabeth R. Berger United States
Philip Diller United States
Osnat Ezra Israel
Yu Ri Im United Kingdom
Ming Shi China
Pam S. Dellea United States
Fiona Grimm
Citations per year, relative to Fiona Grimm Fiona Grimm (= 1×) peers Talita Antunes Guimarães

Countries citing papers authored by Fiona Grimm

Since Specialization
Citations

This map shows the geographic impact of Fiona Grimm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona Grimm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona Grimm more than expected).

Fields of papers citing papers by Fiona Grimm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona Grimm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona Grimm. The network helps show where Fiona Grimm may publish in the future.

Co-authorship network of co-authors of Fiona Grimm

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona Grimm. A scholar is included among the top collaborators of Fiona Grimm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona Grimm. Fiona Grimm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Grimm, Fiona, Mariana Silva dos Santos, Jens Kleinjung, et al.. (2024). Metabolic priming by multiple enzyme systems supports glycolysis, HIF1α stabilisation, and human cancer cell survival in early hypoxia. The EMBO Journal. 43(8). 1545–1569. 6 indexed citations
2.
D'Aeth, Joshua C, Fiona Grimm, David Haw, et al.. (2023). Optimal Hospital Care Scheduling During the SARS-CoV-2 Pandemic. Management Science. 69(10). 5923–5947. 7 indexed citations
3.
Grimm, Fiona, et al.. (2022). Conditions associated with the initiation of domiciliary care following a hospital admission: a cohort study in East London, England. BMJ Open. 12(9). e061875–e061875. 2 indexed citations
5.
Roselló, Alicia, Rosanna C. Barnard, David R. Smith, et al.. (2022). Impact of non-pharmaceutical interventions on SARS-CoV-2 outbreaks in English care homes: a modelling study. BMC Infectious Diseases. 22(1). 324–324. 14 indexed citations
6.
Grimm, Fiona, et al.. (2022). Children and young people’s mental health in England, Scotland and Wales – case studies using linked data from the Networked Data Lab.. International Journal for Population Data Science. 7(3). 1 indexed citations
7.
D'Aeth, Joshua C, Fiona Grimm, David Haw, et al.. (2021). Optimal national prioritization policies for hospital care during the SARS-CoV-2 pandemic. Nature Computational Science. 1(8). 521–531. 14 indexed citations
8.
Grimm, Fiona, et al.. (2021). Hospital admissions from care homes in England during the COVID-19 pandemic: a retrospective, cross-sectional analysis using linked administrative data. International Journal for Population Data Science. 5(4). 1663–1663. 15 indexed citations
9.
Grimm, Fiona, et al.. (2021). Adult social care and COVID-19 after the first wave: assessing the policy response in England. 5 indexed citations
10.
Morotti, Matteo, Esther Bridges, Alessandro Valli, et al.. (2019). Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer. Proceedings of the National Academy of Sciences. 116(25). 12452–12461. 105 indexed citations
11.
Driscoll, Paul C., Fiona Grimm, Patrícia M. Nunes, et al.. (2018). MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG. Nature Chemical Biology. 14(11). 1032–1042. 19 indexed citations
12.
Grimm, Fiona, et al.. (2016). Gas Chromatography Coupled to Mass Spectrometry (GC–MS) to Study Metabolism in Cultured Cells. Advances in experimental medicine and biology. 899. 59–88. 4 indexed citations
13.
Mirtschink, Peter, Jaya Krishnan, Fiona Grimm, et al.. (2015). HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease. Nature. 522(7557). 444–449. 131 indexed citations
14.
Handrick, René, et al.. (2010). 369 Dihydroartemisinin is a hypoxia active anticancer drug. European Journal of Cancer Supplements. 8(5). 94–94. 2 indexed citations
15.
Grimm, Fiona, et al.. (1989). [Dexamethasone and prednisolone use in pigeons].. PubMed. 17(2). 167–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026